| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,849 |
5,620 |
$796K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,899 |
2,773 |
$616K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,102 |
2,969 |
$556K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
716 |
694 |
$128K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,098 |
1,081 |
$117K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
713 |
672 |
$105K |
| 70450 |
Computed tomography, head or brain; without contrast material |
375 |
363 |
$66K |
| 80053 |
Comprehensive metabolic panel |
3,659 |
3,323 |
$57K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,390 |
387 |
$56K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
882 |
881 |
$52K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
396 |
353 |
$37K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
312 |
307 |
$21K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,274 |
1,218 |
$18K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
80 |
79 |
$17K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
111 |
110 |
$17K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
239 |
236 |
$7K |
| 71046 |
Radiologic examination, chest; 2 views |
1,867 |
1,804 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
627 |
587 |
$6K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,018 |
973 |
$5K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
14 |
13 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,792 |
4,287 |
$2K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,412 |
1,395 |
$2K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,978 |
1,854 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
85 |
85 |
$2K |
| 97162 |
|
16 |
16 |
$2K |
| 97163 |
|
17 |
16 |
$1K |
| 81025 |
|
646 |
624 |
$1K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,382 |
2,003 |
$1K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
155 |
155 |
$1K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
13 |
13 |
$1K |
| 81001 |
|
2,767 |
2,587 |
$932.94 |
| 84484 |
|
1,473 |
1,351 |
$845.47 |
| 83690 |
|
1,632 |
1,524 |
$670.98 |
| 83735 |
|
1,155 |
1,083 |
$637.51 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,383 |
1,303 |
$578.86 |
| 36415 |
Collection of venous blood by venipuncture |
544 |
499 |
$549.27 |
| 90715 |
|
17 |
14 |
$479.79 |
| 83605 |
|
324 |
287 |
$479.34 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
12 |
12 |
$459.13 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
540 |
518 |
$425.10 |
| 73630 |
|
90 |
88 |
$354.37 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,238 |
1,401 |
$337.76 |
| 76642 |
|
13 |
13 |
$336.03 |
| 80076 |
|
40 |
39 |
$329.41 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
149 |
134 |
$308.92 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
986 |
928 |
$267.76 |
| 71045 |
Radiologic examination, chest; single view |
311 |
301 |
$249.01 |
| 84443 |
Thyroid stimulating hormone (TSH) |
37 |
36 |
$217.77 |
| 87088 |
|
253 |
242 |
$190.92 |
| 85379 |
|
104 |
103 |
$157.42 |
| 72100 |
|
14 |
13 |
$94.48 |
| 73610 |
|
36 |
36 |
$70.68 |
| 80061 |
Lipid panel |
12 |
12 |
$62.43 |
| 84703 |
|
539 |
523 |
$58.99 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
959 |
897 |
$49.45 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
17 |
14 |
$45.00 |
| 73030 |
|
12 |
12 |
$41.35 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
30 |
26 |
$41.25 |
| 87040 |
|
102 |
95 |
$40.75 |
| 87077 |
|
39 |
39 |
$25.55 |
| 85730 |
|
13 |
13 |
$18.57 |
| 73130 |
|
12 |
12 |
$15.16 |
| 73110 |
|
12 |
12 |
$15.16 |
| 85610 |
|
13 |
13 |
$11.73 |
| 81003 |
|
77 |
77 |
$10.10 |
| 87807 |
|
41 |
39 |
$5.70 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
44 |
41 |
$3.07 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
12 |
12 |
$2.24 |
| A9270 |
Non-covered item or service |
3,880 |
3,397 |
$1.83 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
17 |
16 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12 |
12 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
478 |
417 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
12 |
12 |
$0.00 |
| 87186 |
|
12 |
12 |
$0.00 |